|
1
|
Wertheim I, Fleischhacker D, McLachlin CM,
Rice LW, Berkowitz RS and Goff BA: Pseudomyxoma Peritonei: a review
of 23 cases. Obstet Cynecol. 84:17–21. 1994.PubMed/NCBI
|
|
2
|
Guo AT, Song X, Wei LX and Zhao P:
Histological origin of pseudomyxoma peritonei in Chinese women:
clinicopathology and immunohistochemistry. World J Gastroenterol.
17:3531–3537. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sugarbaker PH: Cytoreductive surgery and
peri-operative intraperitoneal chemotherapy as a curative approach
to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 27:239–243.
2001. View Article : Google Scholar
|
|
4
|
Young RH, Gilks CB and Scully RE: Mucinous
tumors of the appendix associated with mucinous tumors of the ovary
and pseudomyxoma peritonei. A clinicopathological analysis of 22
cases supporting an origin in the appendix. Am J Surg Pathol.
15:415–429. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szych C, Staebler A, Connolly DC, et al:
Molecular genetic evidence supporting the clonality and appendiceal
origin of Pseudomyxoma peritonei in women. Am J Pathol.
154:1849–1855. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Z, Mo CC, Zhuang JY and Deng ZH:
Pseudomixoma peritonei associated with ovary and omentum majus: 1
case report. Journal of Guiyang Medical College. 28:186–192.
2003.(In Chinese).
|
|
7
|
Miner TJ, Shia J, Jaques DP, Klimstra DS,
Brennan MF and Coit DG: Long-term survival following treatment of
pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg.
241:300–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elias D, Gilly F, Quenet F, Bereder JM, et
al: Pseudomyxoma peritonei: A French multicentric study of 301
patients treated with cytoreductive surgery and intraperitoneal
chemotherapy. Eur J Surg Oncol. 36:456–462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smeenk RM, Verwaal VJ, Antonini N and
Zoetmulder FA: Survival analysis of pseudomyxoma peritonei patients
treated by cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy. Ann Surg. 245:104–109. 2007. View Article : Google Scholar
|
|
10
|
Hsieh SY, Chiu CT, Sheen IS, Lin DY and Wu
CS: A clinical study on pseudomyxoma peritonei. J Gastroenterol
Hepatol. 10:86–91. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carmignani CP, Hampton R, Sugarbaker CE,
Chang D and Sugarbaker PH: Utility of CEA and CA19–9 tumor markers
in diagnosis and prognostic assessment of mucinous epithelial
cancers of the appendix. J Surg Oncol. 87:162–166. 2004.
|
|
12
|
Baratti D, Kusamura S, Martinetti A,
Seregni E, Laterza B, Oliva DG and Deraco M: Prognostic value of
circulating tumor markers in patients with pseudomyxoma peritonei
treated with cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy. Ann Surg Oncol. 14:2300–2308. 2007. View Article : Google Scholar
|
|
13
|
Lee JK, Song SH, Kim I, Lee KH, Kim BG,
Kim JW, Kim YT, Park SY, Cha MS and Kang SB: Retrospective
multicenter study of a clinicopathologic analysis of pseudomixoma
peritonei associated with ovarian tumors (KGOG 3005). Int J Gynecol
Cancer. 18:916–920. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miner TJ, Shia J, Jaques DP, et al:
Long-term survival following treatment of pseudomixoma peritonei:
an analysis of surgical therapy. Ann Surg. 241:300–308. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baratti D, Kusamura S, Nonaka D, et al:
Pseudomixoma Peritonei: clinical pathological and biological
prognostic factors in patients treated with cytoreductive surgery
and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg
Oncol. 15:526–534. 2008. View Article : Google Scholar
|
|
16
|
Ronnett BM, Yan H, Kurman RJ, Shmookler
BM, Wu L and Sugarbaker PH: Patients with pseudomyxoma peritonei
associated with disseminated peritoneal adenomucinosis have a
significantly more favorable prognosis than patients with
peritoneal mucinous carcinomatosis. Cancer. 92:85–91. 2001.
View Article : Google Scholar
|
|
17
|
Elias D, Honoré C, Ciuchendéa R, et al:
Peritoneal pseudomyxoma: results of a systematic policy of complete
cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy. Br J Surg. 95:1164–1171. 2008. View Article : Google Scholar
|
|
18
|
Sugarbaker PH: Pseudomyxoma peritonei: a
cancer whose biology is characterized by a redistribution
phenomenon. Ann Surg. 219:109–111. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu B and Wu HP: Dignosis and treatment of
Pseudomyxoma peritonei: 5 cases report. Journal of Abdominal
Surgery. 10:228–229. 1997.(In Chinese).
|
|
20
|
Spratt JS, Adcock RA, Sherrill W and
Travathen S: Hyperthermic peritoneal perfusion system in canines.
Cancer Res. 40:253–255. 1980.PubMed/NCBI
|
|
21
|
Zhang SH and Liu ZL: Pseudomyxoma
peritonei: the treatment experience of 9 cases. Chinese Journal of
Clinical Oncology. 26:1–12. 1999.(In Chinese).
|
|
22
|
Sugarbaker PH: Pseudomyxoma peritonei. A
cancer whose biology is characterized by a redistribution
phenomenon. Ann Surg. 219:109–111. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sugarbaker PH: Cytoreductive surgery and
peri-operative intraperitoneal chemotherapy as a curative approach
to pseudomyxoma peritonei syndrome. Eur J surg Oncol. 27:239–243.
2001. View Article : Google Scholar
|
|
24
|
Deraco M, Kusamura S and Gronchi A:
Cytoreductive surgery (peritonectomy) and intraperitoneal
hyperthermic chemotherapy: an innovative and effective approach to
the treatment of pseudomyxoma peritonei. Tumori. 89:54–55. 2003.(In
Italian).
|
|
25
|
Deraco M, Gronchi A, Mazzaferro V, et al:
Feasibility of peritonectomy associated with intraperitoneal
hyperthermic perfusion in patients with pseudomyxoma peritonei.
Tumori. 88:370–375. 2002.PubMed/NCBI
|
|
26
|
Gough DB, Donohue JH, Schutt AJ, et al:
Pseudomyxoma peritonei. Long tern patient survival with an
aggressive regional approach. Ann Surg. 219:112–119. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan TD, Black D, Savady R and Sugarbaker
PH: A systematic review of the efficacy of cytoreductive surgery
and perioperative intraperitoneal chemotherapy for pseudomyxoma
peritonei. Ann Surg Oncol. 14:484–492. 2007. View Article : Google Scholar : PubMed/NCBI
|
